We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Green Thumb Industries Inc. (GTBIF) Moves 10.0% Higher: Will This Strength Last?
Read MoreHide Full Article
Green Thumb Industries Inc. (GTBIF - Free Report) shares soared 10% in the last trading session to close at $7.92. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 9.8% gain over the past four weeks.
The sharp rise in GTBIF shares can be attributed to renewed optimism around U.S. cannabis reform, particularly expectations that marijuana could be reclassified to Schedule III. This shift would remove the restrictive 280E tax burden, materially improving margins and cash flows for multi-state operators like Green Thumb Industries Inc. The broader sector rally driven by this regulatory catalyst, along with increased investor positioning ahead of potential policy action, further amplified the upside in the stock.
This company is expected to post quarterly loss of $0.01 per share in its upcoming report, which represents a year-over-year change of -125%. Revenues are expected to be $296.78 million, up 6.2% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Green Thumb Industries Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on GTBIF going forward to see if this recent jump can turn into more strength down the road.
Green Thumb Industries Inc. is a member of the Zacks Medical - Products industry. One other stock in the same industry, CeriBell, Inc. (CBLL - Free Report) , finished the last trading session 1.9% higher at $21.33. CBLL has returned 10.7% over the past month.
For CeriBell, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.39. This represents a change of -8.3% from what the company reported a year ago. CeriBell, Inc. currently has a Zacks Rank of #3 (Hold).
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Green Thumb Industries Inc. (GTBIF) Moves 10.0% Higher: Will This Strength Last?
Green Thumb Industries Inc. (GTBIF - Free Report) shares soared 10% in the last trading session to close at $7.92. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 9.8% gain over the past four weeks.
The sharp rise in GTBIF shares can be attributed to renewed optimism around U.S. cannabis reform, particularly expectations that marijuana could be reclassified to Schedule III. This shift would remove the restrictive 280E tax burden, materially improving margins and cash flows for multi-state operators like Green Thumb Industries Inc. The broader sector rally driven by this regulatory catalyst, along with increased investor positioning ahead of potential policy action, further amplified the upside in the stock.
This company is expected to post quarterly loss of $0.01 per share in its upcoming report, which represents a year-over-year change of -125%. Revenues are expected to be $296.78 million, up 6.2% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Green Thumb Industries Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on GTBIF going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Green Thumb Industries Inc. is a member of the Zacks Medical - Products industry. One other stock in the same industry, CeriBell, Inc. (CBLL - Free Report) , finished the last trading session 1.9% higher at $21.33. CBLL has returned 10.7% over the past month.
For CeriBell, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.39. This represents a change of -8.3% from what the company reported a year ago. CeriBell, Inc. currently has a Zacks Rank of #3 (Hold).